iRobot (IRBT) Q3 2024 earnings summary

Executive summary

• Leadership transition underway with new CFO and CHRO appointments following retirements, alongside significant operational restructuring and a 50% workforce reduction since the start of 2024.

• The iRobot Elevate turnaround strategy focuses on operational changes, cost reductions, and new product innovation, with major product launches and a refresh planned for 2025.

• Revenue for the nine months ended September 28, 2024 declined 12.6% year-over-year to $509.8 million, driven by lower orders amid weak consumer sentiment and increased competition.

• The company received a $94.0 million termination fee from Amazon after the mutual termination of their merger agreement, using part of the proceeds to repay debt and support liquidity.

• Despite margin improvements, overall results missed expectations due to persistent macroeconomic and competitive headwinds impacting consumer demand and sell-through.

Financial highlights

• Q3 2024 revenue was $193.4 million, up from $186.2 million in Q3 2023, with domestic revenue up 23% and international revenue down 12%.

• Q3 2024 gross margin expanded to 32.4% (non-GAAP) and 32.2% (GAAP), up from 26.5% and 25.8% respectively, year-over-year.

• Q3 2024 operating expenses dropped 47% year-over-year to $47.7 million (non-GAAP), aided by a $13.5 million one-time IP litigation settlement.

• Q3 2024 operating income was $15.1 million (non-GAAP) and $7.3 million (GAAP), compared to losses last year; Q3 net income per share was $0.03 (non-GAAP) and net loss per share was $0.21 (GAAP).

• Ended Q3 with $99.4 million in cash and $41.1–$42.4 million in restricted cash.

Outlook and guidance

• Q4 2024 revenue expected between $175 million and $200 million; gross margin 24%–27% (up from 18.9% in Q4 2023).

• Q4 operating loss projected at $31 million–$22 million (non-GAAP); net loss per share $1.50–$1.20.

• Full-year 2024 revenue guidance lowered to $685 million–$710 million; gross margin 25%–26%; operating margin negative 15% to negative 13%.

• Full-year net loss per share expected between $4.91 and $4.60 (non-GAAP); GAAP net loss per share $4.27–$3.96.

• Anticipates return to year-over-year top-line growth in 2025, with stronger performance in the second half as new products ramp.